Trial intelligence / Profile preview

Extended Interval of INR Follow-up in VA Anticoagulation Service

NCT02392104Completed

Sponsor
William S. Middleton Memorial Veterans Hospital
Start
Mar 2015
Primary completion
Jun 2017
Modality
Small Molecules
01

Overview

Open-label, single-arm trial of warfarin in thromboembolism, sponsored by William S. Middleton Memorial Veterans Hospital. Primary endpoints: Rates of Participant Accrual at 2.25 years, Number of Participants Able to be Scheduled for at Least One 12-week Interval at 24 months and 1 more. Started Mar 2015; status: completed.

02

Drugs

warfarin
03

Conditions

thromboembolism

Beyond the preview

Go deeper on NCT02392104.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02392104.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call